Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Share-based Compensation (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Share-based Compensation for 6 consecutive years, with $627000.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 9.0% to $627000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Dec 2025, up 4.1% year-over-year, with the annual reading at $4.0 million for FY2025, 4.1% up from the prior year.
  • Share-based Compensation hit $627000.0 in Q4 2025 for Rapid Micro Biosystems, down from $1.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $1.3 million in Q2 2022 to a low of $191000.0 in Q1 2021.
  • Historically, Share-based Compensation has averaged $925950.0 across 5 years, with a median of $1.0 million in 2023.
  • Biggest five-year swings in Share-based Compensation: soared 414.66% in 2022 and later tumbled 32.58% in 2024.
  • Year by year, Share-based Compensation stood at $678000.0 in 2021, then soared by 62.98% to $1.1 million in 2022, then decreased by 7.51% to $1.0 million in 2023, then crashed by 32.58% to $689000.0 in 2024, then dropped by 9.0% to $627000.0 in 2025.
  • Business Quant data shows Share-based Compensation for RPID at $627000.0 in Q4 2025, $1.1 million in Q3 2025, and $1.2 million in Q2 2025.